New Combination Therapy Safe, Promising For Melanoma Patients
Sunday, June 1, 2008 - 16:35
in Health & Medicine
Researchers in the melanoma and skin cancer program at the University of Pittsburgh Cancer Institute combined two biotherapies, high-dose interferon alfa-2b and tremelimumab, and found the combination may be beneficial for patients with inoperable melanoma. The study has since moved into the second stage, where it will enroll 21 additional patients.
Read the whole article on Science Daily
More from Science Daily
Related
- New combination therapy safe, promising for melanoma patientsSun, 1 Jun 2008, 14:35:45 EDT
- New treatment combination safe for pancreatic cancer patientsMon, 2 Jun 2008, 9:22:00 EDT
- Vaccine shows therapeutic promise against advanced melanomaMon, 1 Jun 2009, 9:44:24 EDT
- Combination therapy packs 1-2 punch against melanomaSun, 1 Jun 2008, 15:21:28 EDT
- New treatment combination proves safe, effective for head and neck cancer patientsMon, 2 Jun 2008, 17:14:58 EDT